Testing effectiveness (Phase 2)Looking for participantsNCT06930261
What this trial is testing
Dopaminergic Disruption Induced by Traumatic Coma: Dopaminergic Pathways Abnormalities and Biomarkers of Recovery Using MRI and 18F-LBT-999 PET
Who this might be right for
Coma, Traumatic
Institut National de la Santé Et de la Recherche Médicale, France 55